Makale detayı · 2024
The epithelial barrier theory and its associated diseases
Dergi
ALLERGYISSN 0105-4538
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
- Yıl
- 2024
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı ALLERGY
- Katalog eşleşmesi (ISSN) Allergy: European Journal of Allergy and Clinical Immunology
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
OpenAlex · İngilizce
The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, over 350,000 new chemical substances have been introduced to the lives of humans. In recent years, the epithelial barrier theory came to light explaining the growing prevalence and exacerbations of these diseases worldwide. It attributes their onset to a functionally impaired epithelial barrier triggered by the toxicity of the exposed substances, associated with microbial dysbiosis, immune system activation, and inflammation. Diseases encompassed by the epithelial barrier theory share common features such as an increased prevalence after the 1960s or 2000s that cannot (solely) be accounted for by the emergence of improved diagnostic methods. Other common traits include epithelial barrier defects, microbial dysbiosis with loss of commensals and colonization of opportunistic pathogens, and circulating inflammatory cells and cytokines. In addition, practically unrelated diseases that fulfill these criteria have started to emerge as multimorbidities during the last decades. Here, we provide a comprehensive overview of diseases encompassed by the epithelial barrier theory and discuss evidence and similarities for their epidemiology, genetic susceptibility, epithelial barrier dysfunction, microbial dysbiosis, and tissue inflammation.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
158 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 8 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Type 2 immunity in allergic diseases 2025
- The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic Disorders 2025
- Risk and Protective Factors for Infection, Severe Disease, and Mortality in Epidemic Respiratory Viruses 2026
- Epigenetic changes and serotype-specific responses of alveolar type II epithelial cells to Streptococcus pneumoniae in resolving influenza A virus infection 2025
- Behind the scenes: Primary immunodeficiencies in pediatric eosinophilic gastrointestinal diseases 2026
- Role of Corneal Screening in Pediatric Patients With Allergic Rhinoconjunctivitis: A Proactive Approach to Preventive Ophthalmology: Initial Report of the CATCH (Capturing Atopic Children) Keratoconus Study Group 2026
- Failed Mucosal Allostasis Distinguishes Murine IgG ‐ From IgE ‐Mediated Recurrent Severe Anaphylaxis 2026
- A Survey on Environmental Protective and Risk Factors and Awareness Related to Epithelial Barrier Integrity, Microbiome and Allergic Diseases 2025